60 reports

  • ALLERGY RHINITIS DRUGS MARKET IN AMERICAS
  • ALLERGY RHINITIS DRUGS MARKET IN APAC
  • Allergy Drug
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • PL-101 - DRUG PROFILE
  • BM-34 - DRUG PROFILE

BIOMAY AG Ragweed Pollen Allergy - Pipeline by Biomay AG, H## 2017 Ragweed Pollen Allergy - Drug Profiles ALLERR - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Mechanism Of Action AllerR A

  • Allergy Drug
  • United States
  • World
  • Product Initiative
  • Biomay AG
  • PL-101 - DRUG PROFILE

BIOMAY AG Ragweed Pollen Allergy - Pipeline by Astellas Pharma Inc, H## 2017 Ragweed Pollen Allergy - Pipeline by Biomay AG, H## 2017 Ragweed Pollen Allergy - Drug Profiles ALLERR - DRUG PROFILE Drug Name Company/ Institute Name Licensed From C

  • Allergy Drug
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • PEANUT ALLERGY VACCINE - DRUG PROFILE
  • Allergy Drug
  • United States
  • World
  • Product Initiative
  • DBV Technologies S.A.
  • 2.5 Types of Allergy by Allergens
  • Types of Allergy
  • Allergy Drug
  • World
  • Market Size
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • form 1 of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1 -piperidinyl] ethyl]-alpha alpha-dimethylbenzene...
  • ALLERGEN FOR ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS - DRUG PROFILE

The drug candidate is an immunotherapy.

  • Allergy Drug
  • Therapy
  • World
  • Product Initiative
  • Allergy Therapeutics plc

Drug Allergy ##. ##. ##.

  • Allergy Drug
  • OTC
  • World
  • Market Size
  • VACCINE FOR PEANUT ALLERGY - DRUG PROFILE
  • VACCINE 2 FOR PEANUT ALLERGY - DRUG PROFILE
  • Allergy Drug
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • Allergy Therapeutics
  • ALK-Abello

This drug is indicated for the treatment of grass allergy.

  • Allergy Drug
  • Market Size
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • Allergy Drugs Industry Structure
  • Allergy Drugs Companies in China
  • Allergy Drug
  • China
  • Eisai Co., Ltd.
  • Sanofi-Synthelabo Inc.
  • Schering-Plough China Inc.
  • IV. ALLERGY DRUGS PRODUCTION AND DEMAND
  • Allergy Drugs Industry Forecasts - China Focus
  • Allergy Drug
  • China
  • Demand
  • Market Size
  • Trade
  • Allergy Drugs Industry Structure
  • Allergy Drugs Market Outlook Overview
  • Allergy Drug
  • China
  • Market Size
  • Eisai Co., Ltd.
  • Schering-Plough China Inc.
  • PL-101 - DRUG PROFILE

Its pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy.

  • Allergy Drug
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • House Dust Mite Allergy - Drug Profiles
  • PL-103 - DRUG PROFILE
  • Allergy Drug
  • Japan
  • World
  • Product Initiative
  • Anergis SA
  • Cedar Pollen Allergy - Drug Profiles
  • VACCINE FOR CEDAR POLLEN ALLERGY - DRUG PROFILE
  • Allergy Drug
  • Therapy
  • Vaccine
  • Japan
  • Product Initiative
  • Vendor landscape

The segment designs, manufactures, and markets drugs and pharmaceuticals to treat epilepsy, allergy, cognitive disorders, and hyper acidity drugs.

  • Allergy Drug
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Cedar Pollen Allergy - Drug Profiles
  • VACCINE FOR CEDAR POLLEN ALLERGY - DRUG PROFILE
  • Allergy Drug
  • Therapy
  • Vaccine
  • Japan
  • Product Initiative
  • 5.1 INTRODUCTION

SOME COMMON TRIGGERS FOR DRUG ALLERGIES ARE PENICILLIN, SULFA DRUGS, ANTICONVULSANTS, ASPIRIN, IBUPROFEN, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), AND CHEMOTHERAPY DRUGS.

  • Allergy Drug
  • Europe
  • World
  • Market Size
  • Danaher Corporation
  • form 1 of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1 -piperidinyl] ethyl]-alpha alpha-dimethylbenzene...
  • Chronic Urticaria Or Hives - Product Development Milestones

Nov ##, 2016: Taiho and Meiji Announce the Launch of Bilanoa Tablets ## mg, an Oral Anti-allergy Drug in Japan Taiho Pharmaceutical Co., Ltd. and Meiji Seika Pharma Co., Ltd. announced the launch of Bilanoa Tablets ## mg (generic name: bilastine), an oral anti-allergy

  • Allergy Drug
  • Hospital
  • Pharmaceutical
  • Canada
  • Product Initiative
  • Perennial Allergic Rhinitis - Therapeutics Assessment

INS products such as Nasacort Allergy ##HRTM are recommended as the most effective drugs for the treatment of allergic rhinitis##.

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.
  • Faes Farma SA, Subsidiaries

Mariano ucar, president and CEO of Faes Farma, said, " Faes shall have the opportunity to provide Canadian patients direct access to the innovative Bilastine drug, in the allergy and dermatology fields.

  • Allergy Drug
  • Spain
  • Company Operations
  • Deals & Alliance
  • Faes Farma S.A.
  • BILASTINE - DRUG PROFILE

Its products include anti-inflammatory pain relieving patches, antifungal drugs, analgesic drugs, dermatological drugs, cosmetics, quasi drugs, respiratory system drugs and others.

  • Allergy Drug
  • OTC
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.
  • Birch Pollen Allergy - Drug Profiles
  • Vaccine for Birch Pollen Allergy
  • Allergy Drug
  • Europe
  • World
  • Product Initiative
  • Anergis SA

Additionally, unpredictable allergies (with potentially severe reactions) to drugs and biological agents are becoming problematic.

  • Allergy Drug
  • Asia
  • World
  • Forecast
  • Market Size
  • R&D Progress

Adamis and Beximco intend to introduce a number of separate drugs into the U. S. over the next years in the allergy and respiratory areas and may co-develop certain drugs.

  • Allergy Drug
  • OTC
  • Pharmaceutical
  • Respiratory Disease
  • Pfizer Inc.
  • ALLERGEN FOR ALLERGY - DRUG PROFILE
  • BIOSIMILAR FOR ALLERGY - DRUG PROFILE
  • Allergy Drug
  • Research And Development
  • United States
  • Company
  • Product Initiative
  • Drug Profiles

Adamis and Beximco intend to introduce a number of separate drugs into the U. S. over the next years in the allergy and respiratory areas and may co-develop certain drugs.

  • Allergy Drug
  • OTC
  • Pharmaceutical
  • Respiratory Disease
  • Pfizer Inc.

In July 2011, Oxagen Limited announced publication of data from a Phase IIa clinical trial of its development drug OC## in the journal Clinical & Experimental Allergy.

  • Allergy Drug
  • Asthma
  • United States
  • World
  • Product Initiative
  • 3. Global Allergy Therapeutics Market: An Analysis

Since ## ALK has been working to improve the quality of life for allergy patients by developing drugs that target the cause of allergy.

  • Allergy Drug
  • Europe
  • Allergy Therapeutics plc
  • Circassia Pharmaceuticals plc
  • Stallergenes SA
  • Birch Pollen Allergy - Drug Profiles
  • VACCINE FOR BIRCH POLLEN ALLERGY - DRUG PROFILE
  • Allergy Drug
  • United States
  • World
  • Product Initiative
  • Anergis SA